Laura Rillo-De Armas

Santa Cruz De Tenerife, CN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease.

Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease.

Journal: International journal of molecular sciences

Published: February 11, 2023

Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III.

Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III.

Journal: Clinical and experimental rheumatology

Published: December 12, 2021

Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis.

Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis.

Journal: Arthritis research & therapy

Published: December 06, 2021

Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus.

Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus.

Journal: Frontiers in immunology

Published: December 01, 2021

Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease.

Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease.

Journal: Clinical and translational gastroenterology

Published: November 01, 2021

The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis.

The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis.

Journal: Arthritis research & therapy

Published: July 19, 2021

Amylin serum levels are upregulated in patients with systemic lupus erythematosus.

Amylin serum levels are upregulated in patients with systemic lupus erythematosus.

Journal: Clinical and experimental rheumatology

Published: July 02, 2021

Proprotein convertase subtilisin/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus.

Proprotein convertase subtilisin/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus.

Journal: Therapeutic advances in musculoskeletal disease

Published: August 20, 2020

HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis.

HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis.

Journal: Arthritis research & therapy

Published: August 20, 2020

The Number of Traditional Cardiovascular Risk Factors Is Independently Correlated with Disease Activity in Patients with Psoriatic Arthritis.

The Number of Traditional Cardiovascular Risk Factors Is Independently Correlated with Disease Activity in Patients with Psoriatic Arthritis.

Journal: Medicina (Kaunas, Lithuania)

Published: July 20, 2020

Insulin resistance in non-diabetes patients with spondyloarthritis.

Insulin resistance in non-diabetes patients with spondyloarthritis.

Journal: Scandinavian journal of rheumatology

Published: July 11, 2020

Higher Prevalence and Degree of Insulin Resistance in Patients With Rheumatoid Arthritis Than in Patients With Systemic Lupus Erythematosus.

Higher Prevalence and Degree of Insulin Resistance in Patients With Rheumatoid Arthritis Than in Patients With Systemic Lupus Erythematosus.

Journal: The Journal of rheumatology

Published: June 04, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026